Vivo Capital IX, LLC, 10% Owner at Tarsus Pharmaceuticals, Inc. (TARS), sold 63,388 shares at $29.80 ($1.9M) on 2021-06-23, disclosed to the SEC on 2021-06-25.
Open-market sale of $1.9M TARS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.80 | 37,980 | $1.1M | 60.0% |
| 2 | $29.90 | 10,000 | $299K | 15.8% |
| 3 | $29.60 | 7,704 | $228K | 12.1% |
| 4 | $29.60 | 7,704 | $228K | 12.1% |
| Total | $29.77 avg | 63,388 | $1.9M | 100% |
| Filing → |
| TARS | SELL | 2021-06-25 | $5.9M | — | Filing → |
| TARS | SELL | 2021-04-16 | $12K | — | Filing → |